WP
TMO icon

WMS Partners’s Thermo Fisher Scientific TMO Stock Holding History

WMS Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-830
Closed -$432K – 242
2024
Q4 		$432K Buy
830
+135
+19% +$74.2K 0.02% 202
2024
Q3 		$430K Sell
695
-392
-36% -$232K 0.02% 195
2024
Q2 		$601K Sell
1,087
-26
-2% -$14.9K 0.04% 139
2024
Q1 		$647K Buy
1,113
+52
+5% +$29.2K 0.04% 135
2023
Q4 		$563K Sell
1,061
-543
-34% -$263K 0.04% 146
2023
Q3 		$812K Sell
1,604
-234
-13% -$125K 0.06% 110
2023
Q2 		$959K Buy
1,838
+28
+2% +$15.1K 0.08% 106
2023
Q1 		$1.04M Sell
1,810
-47
-3% -$26.5K 0.09% 92
2022
Q4 		$1.02M Sell
1,857
-44
-2% -$23.3K 0.1% 96
2022
Q3 		$964K Buy
1,901
+15
+0.8% +$8.39K 0.13% 90
2022
Q2 		$1.02M Sell
1,886
-75
-4% -$41.3K 0.16% 83
2022
Q1 		$1.16M Buy
+1,961
New +$1.13M 0.16% 74
2021
Q4 		– Sell
-3,399
Closed -$1.94M – 262
2021
Q3 		$1.94M Buy
3,399
+503
+17% +$276K 0.28% 49
2021
Q2 		$1.46M Sell
2,896
-94
-3% -$44.4K 0.22% 58
2021
Q1 		$1.36M Sell
2,990
-540
-15% -$258K 0.31% 52
2020
Q4 		$1.64M Buy
3,530
+87
+3% +$40.8K 0.28% 48
2020
Q3 		$1.52M Sell
3,443
-127
-4% -$52.5K 0.3% 50
2020
Q2 		$1.29M Buy
3,570
+13
+0.4% +$4.36K 0.27% 55
2020
Q1 		$1.01M Buy
3,557
+65
+2% +$20.5K 0.28% 55
2019
Q4 		$1.14M Sell
3,492
-1,325
-28% -$402K 0.25% 57
2019
Q3 		$1.4M Buy
4,817
+1,913
+66% +$548K 0.34% 49
2019
Q2 		$853K Buy
2,904
+761
+36% +$210K 0.21% 69
2019
Q1 		$587K Hold
2,143
– – 0.15% 90
2018
Q4 		$480K Buy
2,143
+1,135
+113% +$266K 0.13% 100
2018
Q3 		$246K Hold
1,008
– – 0.03% 190
2018
Q2 		$209K Sell
1,008
-112
-10% -$23.8K 0.02% 206
2018
Q1 		$231K Buy
+1,120
New +$235K 0.03% 197

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

WMS Partners's TMO Position: Q1 2025 in Review

WMS Partners sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 830 shares — an estimated $432K sold.

WMS Partners first reported a position in TMO in Q1 2018 and held it in 27 quarters. The position peaked at $1.94M in Q3 2021. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • WMS Partners reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • WMS Partners sold 830 Thermo Fisher Scientific shares in Q1 2025, an estimated $432K.
  • WMS Partners first reported a position in Thermo Fisher Scientific in Q1 2018 and held it in 27 quarters.
  • WMS Partners's Thermo Fisher Scientific position peaked at $1.94M in Q3 2021.
  • 2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on WMS Partners's 13F filing for Q1 2025.